Five notes:
1. Johnson & Johnson reported $24.7 billion in first quarter sales, a 5.6 percent increase year-over-year.
2. Orthopedic sales of $2.2 billion was a 2.6 percent increase compared to the same time in 2022.
3. Hip sales were $390 million, up slightly from $389 million in the first quarter of 2022. Knee sales grew 8.7 percent year-over-year with $368 million. Trauma sales rose 1.2 percent year-over-year with $757 million in sales.
4. The spine and sports medicine segment rose 2.4 percent year-over-year with $729 million.
5. Johnson & Johnson’s MedTech business saw a 6.4 percent increase year-over-year in sales, largely driven by electrophysiology products, contect lenses, knee products and wound closure products.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
